180 related articles for article (PubMed ID: 10810406)
21. [Radiotherapy of cancer limited to the vocal cords].
Lusinchi A; Luboinski B; Wibault P; Dube P; Janot F; Vericel R; Eschwege F
Ann Otolaryngol Chir Cervicofac; 1989; 106(8):577-82. PubMed ID: 2694896
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic vertical partial laryngectomy.
Davis RK; Hadley K; Smith ME
Laryngoscope; 2004 Feb; 114(2):236-40. PubMed ID: 14755197
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
[TBL] [Abstract][Full Text] [Related]
24. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
25. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
26. T1 glottic carcinoma involving the anterior commissure.
Shvero J; Hadar T; Segal K; Yaniv E; Marshak G; Feinmesser R
Eur J Surg Oncol; 1994 Oct; 20(5):557-60. PubMed ID: 7926059
[TBL] [Abstract][Full Text] [Related]
27. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
[TBL] [Abstract][Full Text] [Related]
28. [Radiotherapy in glottic T1 carcinoma. Local control and survival].
Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C
Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934
[TBL] [Abstract][Full Text] [Related]
29. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
[TBL] [Abstract][Full Text] [Related]
30. Failure of radiation therapy in stage I and II glottic squamous cell carcinoma.
Witt RL
Del Med J; 1995 Aug; 67(8):430-5. PubMed ID: 7664954
[TBL] [Abstract][Full Text] [Related]
31. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
[TBL] [Abstract][Full Text] [Related]
32. Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field.
Chatani M; Matayoski Y; Masaki N; Teshima T; Inoue To
Strahlenther Onkol; 1996 Mar; 172(3):169-72. PubMed ID: 8721266
[TBL] [Abstract][Full Text] [Related]
33. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
34. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
35. Quality control in planning and technique of radiotherapy with cobalt-60 for T1 glottic cancer increase local control and organ preservation.
Cortes-Arroyo H; Rodríguez-Cuevas S; Labastida S
Am J Surg; 1997 Nov; 174(5):477-80. PubMed ID: 9374218
[TBL] [Abstract][Full Text] [Related]
36. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
Jones AS; Fish B; Fenton JE; Husband DJ
Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
[TBL] [Abstract][Full Text] [Related]
37. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
38. [An evaluation of surgical techniques and oncologic results in early glottic cancers].
Gürbüz MK; Ozüdoğru EN; Cakli H; Cingi E; Keçik MC; Cingi C
Kulak Burun Bogaz Ihtis Derg; 2003 May; 10(5):194-8. PubMed ID: 12970592
[TBL] [Abstract][Full Text] [Related]
39. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
